Wave Life Sciences
85 hedge funds and large institutions have $417M invested in Wave Life Sciences in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 7 closing their positions.
663% more call options, than puts
Call options by funds: $244K | Put options by funds: $32K
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
59% more capital invested
Capital invested by funds: $263M → $417M (+$155M)
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
5% more funds holding
Funds holding: 81 → 85 (+4)
0% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 28
0.02% less ownership
Funds ownership: 73.36% → 73.35% (-0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$5.61M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.54M |
| 3 |
BlackRock
New York
|
+$1.09M |
| 4 |
Goldman Sachs
New York
|
+$1.08M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$743K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$3.97M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.79M |
| 3 |
Millennium Management
New York
|
-$2.31M |
| 4 |
6CM
683 Capital Management
New York
|
-$826K |
| 5 |
Renaissance Technologies
New York
|
-$608K |
WVE Hedge Fund Activity: Q3 2023 in Review
85 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2023, worth a combined $417M — up 59% from $263M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new WVE positions and 7 closed out — a net gain of 4 holders — while 28 added to existing stakes and 28 trimmed.
The largest buyer was Woodline Partners, opening a new position worth an estimated $5.61M. The largest seller was Artal Group, cutting an estimated $3.97M.
- 85 institutional investors held Wave Life Sciences (WVE) as of Q3 2023, up from 81 in Q2 2023.
- Funds reported $417M of Wave Life Sciences stock for Q3 2023, up 59% quarter-over-quarter.
- 11 funds opened new Wave Life Sciences positions in Q3 2023 and 7 closed out, a net change of +4 holders.
- The largest Wave Life Sciences buyer in Q3 2023 was Woodline Partners, an estimated $5.61M added.
- The largest Wave Life Sciences seller in Q3 2023 was Artal Group, an estimated $3.97M sold.
Based on aggregated 13F filings for Q3 2023.